
National Research Corporation NRC
€ 15.18
-4.7%
Quartalsbericht 2026-Q1
hinzugefügt 06.05.2026
National Research Corporation P/CF 2011-2026 | NRC
P/CF Jährlich National Research Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 11.9 | 9.64 | 26.5 | 31.4 | 22.8 | 27.9 | 47.4 | 31.4 | 38.6 | 18.2 | 19.3 | 14.2 | 21.8 | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 47.4 | 9.64 | 24.7 |
P/CF anderer Aktien in der Diagnostik & Forschung
| Name | P/CF | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Myriad Genetics
MYGN
|
227 | $ 4.11 | -18.29 % | $ 381 M | ||
|
Koninklijke Philips N.V.
PHG
|
26.5 | $ 27.23 | 2.95 % | $ 20 B | ||
|
Centogene N.V.
CNTG
|
26.1 | - | -6.23 % | $ 30.6 M | ||
|
Burning Rock Biotech Limited
BNR
|
-40.2 | $ 17.01 | -0.09 % | $ 179 M | ||
|
Agilent Technologies
A
|
28.3 | $ 117.69 | 0.14 % | $ 35.8 B | ||
|
Akumin
AKU
|
1.15 | - | -17.87 % | $ 25.9 M | ||
|
Aspira Women's Health
AWH
|
-1.41 | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
-0.826 | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
-0.447 | - | -13.05 % | $ 7.29 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
-47.7 | - | - | $ 562 M | ||
|
CareDx, Inc
CDNA
|
23.6 | $ 20.94 | 1.16 % | $ 1.12 B | ||
|
Chembio Diagnostics
CEMI
|
-0.991 | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
-0.541 | - | - | $ 9.42 M | ||
|
HTG Molecular Diagnostics
HTGM
|
-0.162 | - | -20.0 % | $ 1.06 M | ||
|
Co-Diagnostics
CODX
|
-0.201 | $ 1.64 | 3.14 % | $ 2.18 M | ||
|
Castle Biosciences
CSTL
|
7.33 | $ 24.75 | 0.61 % | $ 687 M | ||
|
Global Cord Blood Corporation
CO
|
0.396 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-17.1 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-1.63 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-2.94 | - | 0.12 % | $ 80.1 M | ||
|
Medpace Holdings
MEDP
|
18.2 | - | - | $ 12.3 B | ||
|
DermTech
DMTK
|
-0.551 | - | -11.32 % | $ 2.94 M | ||
|
Charles River Laboratories International
CRL
|
10.4 | $ 181.73 | -1.97 % | $ 9.01 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
21.8 | - | - | $ 10.7 B | ||
|
Enzo Biochem
ENZ
|
-0.00219 | - | -8.98 % | $ 14.8 K | ||
|
NeoGenomics
NEO
|
284 | $ 8.89 | 0.34 % | $ 1.14 B | ||
|
Exact Sciences Corporation
EXAS
|
39.7 | - | - | $ 19.8 B | ||
|
Natera
NTRA
|
-12.3 | $ 215.09 | 4.02 % | $ 21.2 B | ||
|
Fulgent Genetics
FLGT
|
22.2 | $ 14.92 | 0.13 % | $ 451 M | ||
|
Personalis
PSNL
|
-5.62 | $ 6.07 | 9.17 % | $ 360 M | ||
|
Guardant Health
GH
|
-72.7 | $ 92.25 | 3.05 % | $ 11.6 B | ||
|
Heska Corporation
HSKA
|
-38.7 | - | - | $ 1.31 B | ||
|
Soleno Therapeutics
SLNO
|
44.5 | $ 52.94 | 0.04 % | $ 2.69 B | ||
|
ICON Public Limited Company
ICLR
|
12.9 | $ 124.13 | 2.32 % | $ 10.2 B | ||
|
Illumina
ILMN
|
19.6 | $ 142.58 | 2.52 % | $ 22.7 B | ||
|
Senseonics Holdings
SENS
|
-5.93 | $ 5.36 | 7.2 % | $ 224 M | ||
|
Interpace Biosciences
IDXG
|
1.26 | - | - | $ 9.33 M | ||
|
QIAGEN N.V.
QGEN
|
12.6 | - | - | $ 10.6 B | ||
|
Thermo Fisher Scientific
TMO
|
25.1 | $ 472.95 | 1.33 % | $ 178 B | ||
|
Biomerica
BMRA
|
-1.87 | $ 2.21 | 1.14 % | $ 5.08 M | ||
|
Trinity Biotech plc
TRIB
|
-46.3 | $ 0.6 | 0.42 % | $ 61.9 M | ||
|
Lantheus Holdings
LNTH
|
13.1 | $ 86.15 | 0.38 % | $ 5.81 B | ||
|
Laboratory Corporation of America Holdings
LH
|
14.6 | $ 256.94 | -0.08 % | $ 21.4 B | ||
|
Twist Bioscience Corporation
TWST
|
-32.8 | $ 59.53 | 4.99 % | $ 3.56 B | ||
|
Celcuity
CELC
|
-35 | - | - | $ 6.52 B | ||
|
Motus GI Holdings
MOTS
|
-0.0884 | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
17.5 | $ 9.18 | -0.97 % | $ 1.99 B | ||
|
Waters Corporation
WAT
|
30.1 | $ 349.53 | 1.98 % | $ 20.8 B | ||
|
Quest Diagnostics Incorporated
DGX
|
12.4 | $ 189.13 | -0.9 % | $ 21 B |